Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Hemant Murthy

BMT · Mayo Clinic Florida

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Hope Rugo

Breast Oncology · City of Hope

View

Dr. Gideon Dosunmu

GI Oncology · Emory Hospital Midtown

View

Dr. Pavlos Msaouel

GU Oncology · MD Anderson Cancer Center

View

Dr. Virginia Borges

Breast Oncology · CU Anschutz Medical Campus

View

Dr. Naval Daver

Leukemia · MD Anderson Cancer Center

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    SHDr. Shernan Holtan

    Dr. Shernan Holtan

    Hematology & Oncology · Bone Marrow Transplant (BMT)
    Roswell Park Comprehensive Cancer Center
    shernan

    Research

    Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703

    2025

    Via Journal of Clinical Oncology

    Research

    High Amphiregulin Expression in Intestinal Biopsies of Pediatric Patients with Severe Acute Graft-Versus-Host Disease

    2025

    Via Transplantation and Cellular Therapy

    Research

    Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant

    2025

    Via medRxiv

    Research

    Accurate prediction of absolute prokaryotic abundance from DNA concentration

    2025

    Via Cell Reports Methods

    Research

    Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703

    2025

    Via Blood Advances

    Research

    Placental growth factor enhances inflammatory toll-like receptor responses in syncytiotrophoblasts

    2025

    Via Placenta

    Research

    ICANS and mortality after CAR-T therapy for NHL patients can be predicted using physical function measures of falls, balance and strength deficits, and use of an assistive device

    2025

    Via Bone Marrow Transplantation

    Research

    Sirolimus use in allogeneic hematopoietic cell transplant recipients: assessing its senotherapeutic role in a high risk population

    2025

    Via Frontiers in Aging

    Research

    Analysis of epidemiologic factors and treatment effects on immunophenotypes in hematologic malignancy patients

    2025

    Via Leukemia & Lymphoma

    Research

    Amphiregulin as a biomarker for monitoring lifethreatening acute graft--host disease: secondary analysis of two prospective clinical trials

    2024

    Via Haematologica

    Research

    The development and flux of the University of Minnesota Survivorship Program: progress, challenges, and opportunities

    2024

    Via Journal of Cancer Survivorship

    Research

    Long- and short-term effects of fecal microbiota transplantation on antibiotic resistance genes: results from a randomized placebo-controlled trial

    2024

    Via Gut Microbes

    Research

    Treatment-Sensitive and Treatment-Dependent Chronic Graft-versus-Host Disease Yield Superior Failure-Free and Overall Survival Compared to Treatment-Resistant Chronic Graft-versus-Host Disease

    2024

    Via Transplantation and Cellular Therapy

    Research

    Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD

    2024

    Via Blood Advances

    Research

    Treatment-Responsive Acute Graft-versus-Host Disease after Post-Transplantation Cyclophosphamide-Based Prophylaxis: Incidence and Clinical Outcomes

    2024

    Via Transplantation and Cellular Therapy